Cargando…
Adalimumab/vedolizumab: SARS-CoV-2 infection: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379044/ http://dx.doi.org/10.1007/s40278-021-00881-y |
Ejemplares similares
-
Adalimumab/vedolizumab: Gastroparesis and COVID infection: case report
Publicado: (2021) -
Adalimumab/ustekinumab/vedolizumab: COVID-19 infection: 7 case reports
Publicado: (2022) -
Adalimumab/golimumab/infliximab: SARS-CoV-2 pneumonia: 3 case reports
Publicado: (2021) -
Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021) -
Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
por: Shahbaz, Shima, et al.
Publicado: (2023)